PHF6

PHD finger protein 6 · Q8IWS0 · PHF6 on Sugi Atlas →

0 patent compounds predicted against PHF6, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PHF6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients PHASE4NOT_YET_RECRUITING
Study in Adult Ph-positive ALL PHASE2UNKNOWN
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma PHASE2WITHDRAWN
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation PHASE2UNKNOWN
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis PHASE1/PHASE2RECRUITING
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer PHASE2COMPLETED
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer PHASE2UNKNOWN
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load PHASE1COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy nanUNKNOWN
IDH1/IDH2 Mutation Frequency in Acute Myeloblastic Patients nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics nanCOMPLETED
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors nanUNKNOWN
Target of Suv420h1/2 in Hepatocytes nanRECRUITING
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia nanCOMPLETED
Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells. nanUNKNOWN
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions nanRECRUITING
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus nanACTIVE_NOT_RECRUITING
Tecfidera Diffusion Tensor Imaging nanCOMPLETED
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. nanCOMPLETED
A Study of the Genetic Analysis of Brain Disorders nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PHF6 binder may also engage these)

ProteinNameSimilarity
Q5R5Z2 1.000 Q5R5Z2 →
Q08DR0 1.000 Q08DR0 →
Q9D4J7 1.000 Q9D4J7 →
Q8WML3 0.987 Q8WML3 →
Q5TKR9 0.986 Q5TKR9 →
Q5XI06 0.986 Q5XI06 →
KAT8 Histone acetyltransferase KAT8 0.985 landscape →
C0SUU8 0.985 C0SUU8 →
Q92613 0.984 Q92613 →
B1B1A0 0.983 B1B1A0 →
Q8VCD7 0.983 Q8VCD7 →
Q9Z1N2 0.983 Q9Z1N2 →
Q9D4H9 0.983 Q9D4H9 →
KAT7 Histone acetyltransferase KAT7 0.983 landscape →
E1C2V1 0.983 E1C2V1 →
A0A286Y9D1 0.983 A0A286Y9D1 →
O94880 0.983 O94880 →
Q28D84 0.983 Q28D84 →
Q4V863 0.983 Q4V863 →
Q5SVQ0 0.983 Q5SVQ0 →
BRPF3 Bromodomain and PHD finger-containing protein 3 0.982 landscape →
Q8BZ21 0.982 Q8BZ21 →
Q5E9T7 0.982 Q5E9T7 →
KDM5B Lysine-specific demethylase 5B 0.982 landscape →
O01738 0.982 O01738 →
P93015 0.982 P93015 →
Q6C710 0.982 Q6C710 →
KAT6B Histone acetyltransferase KAT6B 0.982 landscape →
L3MBTL3 Lethal(3)malignant brain tumor-like protein 3 0.982 landscape →
Q8BMD7 0.982 Q8BMD7 →